Interferon-γ induced increases in intracellular calcium in T lymphocytes from patients with multiple sclerosis precede clinical exacerbations and detection of active lesions on MRI

Martino, G.; Filippi, M.; Martinelli, V.; Brambilla, E.; Gobbi, C.; Comi, G.; Grimaldi, L. M. E.
September 1997
Journal of Neurology, Neurosurgery & Psychiatry;Sep1997, Vol. 63 Issue 3, p339
Academic Journal
No abstract available.


Related Articles

  • Evaluation of Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) as a Response Marker for Interferon beta in Multiple Sclerosis. Nada, Maha; Khaleel, Salma H.; Bayoumy, Iman M.; Hassan, Rania Ahmed // Egyptian Journal of Neurology, Psychiatry & Neurosurgery;Apr2014, Vol. 51 Issue 2, p201 

    Background: Multiple sclerosis is the most common disease of the CNS that causes long and severe disability in young adults. Some patients with relapsing-remitting MS (RRMS) are unresponsive to IFN-β therapy. The Tumor necrosis factor Related Apoptosis Inducing Ligand (TRAIL) level was...

  • Identifying responders and nonresponders to interferon therapy in multiple sclerosis. Prosperini, Luca; Capobianco, Marco; Giannì, Costanza // Degenerative Neurological & Neuromuscular Disease;2014, Vol. 4, p75 

    Interferon beta is a well established disease-modifying agent used for relapsing-remitting multiple sclerosis. Despite treatment, a relevant proportion of patients continue to experience clinical (ie, relapses, worsening of disability) and magnetic resonance imaging (MRI) activity. Early...

  • Interferon-� dose and efficacy: the OPTIMS study. Durelli, L.; Oggero, A.; Verdun, E.; Barbero, P.; Pipieri, A.; Isoardo, G.; Ricci, A.; Clerico, M.; Bradac, G.; Bergamasco, B.; Bergui, M. // Neurological Sciences;Apr2001, Vol. 22 Issue 2, p201 

    Interferon beta (IFN-�) reduces exacerbation rates in patients with relapsing-remitting multiple sclerosis (MS), but some patients do not respond to treatment. Recent studies have shown a clear dose-response effect on the reduction of exacerbation rates, and on burden of disease...

  • Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Abrahamsson, Sofia V.; Angelini, Daniela F.; Dubinsky, Amy N.; Morel, Esther; Oh, Unsong; Jones, Joanne L.; Carassiti, Daniele; Reynolds, Richard; Salvetti, Marco; Calabresi, Peter A.; Coles, Alasdair J.; Battistini, Luca; Martin, Roland; Burt, Richard K.; Muraro, Paolo A. // Brain: A Journal of Neurology;Sep2013, Vol. 136 Issue 9, p2888 

    Autologous haematopoietic stem cell transplantation has been tried as one experimental strategy for the treatment of patients with aggressive multiple sclerosis refractory to other immunotherapies. The procedure is aimed at ablating and repopulating the immune repertoire by sequentially...

  • Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. Larrey, Dominique; Marcellin, Patrick; Freneaux, Eric; Possayre, Dominique; Benhamon, Jean-Pierre; Larrey, D; Marcellin, P; Fréneaux, E; Pessayre, D; Benhamou, J P // JAMA: Journal of the American Medical Association;4/14/89, Vol. 261 Issue 14, p2065 

    Reports on a medical case involving exacerbation of multiple sclerosis after the administration of recombinant human interferon alpha. Case of a 38-year-old man with multiple sclerosis included in a clinical trial assessing the effect of interferon alpha on chronic active non-A, non-B...

  • Lack of Association between Antimyelin Antibodies and Progression to Multiple Sclerosis. Kuhle, Jens; Pohl, Christoph; Mehling, Matthias; Edan, Gilles; Freedman, Mark S.; Hartung, Hans-Peter; Polman, Chris H.; Miller, David H.; Montalban, Xavier; Barkhof, Frederik; Bauer, Lars; Dahms, Susanne; Lindberg, Raija; Kappos, Ludwig; Sandbrink, Rupert // New England Journal of Medicine;1/25/2007, Vol. 356 Issue 4, p371 

    Background: Patients with a single episode of neurologic dysfunction and brain magnetic resonance imaging (MRI) scans suggestive of multiple sclerosis are at high risk for clinically definite multiple sclerosis, but the outcome for individual patients is unpredictable. An increased risk of...

  • Immunology: T-cells.  // Multiple Sclerosis (13524585);Sep99 Supplement, Vol. 5, pS59 

    The article presents abstracts of medical research related to multiple sclerosis. They include "T Lymphocyte Migration in Primary Progressive Multiple Sclerosis: Relation to MRI Lesion Volume," "Activation of Autoimmune T Cells by Dendritic-Like Cells Without Exogenous Antigens," and "Peripheral...

  • Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis. Yoshimura, Satoshi; Ochi, Hirofumi; Isobe, Noriko; Matsushita, Takuya; Motomura, Kyoko; Matsuoka, Takeshi; Minohara, Motozumi; Kira, Jun-ichi // Multiple Sclerosis (13524585);Oct2010, Vol. 16 Issue 10, p1178 

    Background: Within multiple sclerosis lesions, brain-derived neurotrophic factor is detected in neurons and immunocytes. Objective: To clarify brain-derived neurotrophic factor production by peripheral blood immunocytes and its relationship with clinical parameters in multiple sclerosis....

  • Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study. Kalincik, Tomas; Vaneckova, Manuela; Tyblova, Michaela; Krasensky, Jan; Seidl, Zdenek; Havrdova, Eva; Horakova, Dana // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Objectives: To compare clinical and MRI parameters between patients with clinically isolated syndrome and those converting to clinically definite multiple sclerosis within 2 years, to identify volumetric MRI predictors of this conversion and to assess effect of early relapses. Methods: The SET...

  • Newer magnetic resonance techniques and disease activity in multiple sclerosis: new concepts and new concerns. Filippi, M.; Silver, N.C.; Yousry, T.A.; Miller, D.H. // Multiple Sclerosis (13524585);Dec98, Vol. 4 Issue 6, p469 

    Discusses the use of magnetic resonance imaging (MRI) in detecting multiple sclerosis (MS). MRI measures used to detect MS disease activity; Categories of a number of strategies increasing the sensitivity of enhanced MRI in detecting active lesions in MS; Role of the detectable disruption of...


Read the Article


Sign out of this library

Other Topics